Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial
Marissa R Diggs(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Kristine M. Erlandson(University of Colorado Denver), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Maxine Olefsky(Cancer Research And Biostatistics), Craig A. Sponseller, Júlia Karády(Semmelweis University), Amy Shirong Lu(Harvard University), Jana Taron(University Medical Center Freiburg), Borek Foldyna(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Allison Ross Eckard(Medical University of South Carolina), Michael T. Lu(Cancer Research And Biostatistics), Graham Smith, Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Maya Watanabe(Cancer Research And Biostatistics), Adrián Curran(Lexington City Schools)
Cited by 0
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k